what does a glp 1 agonist do GLP-1 Agonists - is it? Mechanisms of GLP-1 Receptor Agonist-Induced

doi: 10.1093/jn/nxab029

The SELECT trial, which included patients with CV disease and overweight or obesity (many also had increased risk for diabetes), showed a reduction in major adverse CV events (defined as CV death, nonfatal heart attack, and nonfatal stroke) of 20% with weekly subcutaneous semaglutide 2.4 mg

doi: 10.1371/journal.pone.0069010

The increase of serum ANP was significantly larger in patients with eGFR 60 ml/min/1.73 m 2 23 [95%CI (17.2)(61.6)] and 9.9 [95%CI (3.8)(34.2)] respectively, p = 0.012)

Abdominal pain: There can be mild or moderate stomach pain for some

Non-diabetic you should follow the same side effect management strategies: slow titration, dietary modification during dose escalation, proactive nutritional monitoring, and ongoing communication with your prescribing doctor